Abstract：Objective To examine the causal relationship between body mass index (BMI) and 25 types of autoimmune diseases (ADs) using Mendelian randomization (MR) study method. Methods The genome-wide association study (GWAS) data for BMI and 25 types of ADs were obtained from IEU OPEN GWAS database. Single nucleotide polymorphisms (SNPs) related to BMI were used as instrumental variables, 25 types of ADs were used as study outcomes, and MR analysis was performed using inverse variance weighted (IVW) method. Heterogeneity was evaluated using Cochran's Q test, horizontal pleiotropy was tested using MR-Egger regression and MR-PRESSO, and results robustness was verified with leave-one-out method. Results Cochran's Q test showed heterogeneity of MR analysis results (P<0.05), and a random effect model was employed. The results of MR analysis showed that elevated BMI increased the incidence risks of type 1 diabetes mellitus (OR=1.519, 95%CI: 1.281-1.801), IgA nephropathy (OR=1.227, 95%CI: 1.134-1.327), adult Still disease (OR=1.002, 95%CI: 1.001-1.003), multiple sclerosis (OR=1.303, 95%CI: 1.115-1.523), narcolepsy (OR=1.029, 95%CI: 1.017-1.040), Hashimoto thyroiditis (OR=1.561, 95%CI: 1.391-1.751), autoimmune hepatitis (OR=1.481, 95%CI: 1.076-2.038), rheumatoid arthritis (OR=1.209, 95%CI: 1.054-1.386), psoriasis vulgaris (OR=1.719, 95%CI: 1.427-2.070) and pernicious anemia (OR=1.001, 95%CI: 1.000-1.002). No causal relationship was found with other ADs (all P>0.05). MR-Egger regression identified no horizontal pleiotropy of instrumental variables (all P>0.05), while MR-PRESSO test identified partial horizontal pleiotropy (all P<0.05), which remained consistent with the original results after adjustment (P>0.05). Leave-one-out analysis showed results robustness. Conclusion There are causal relationship among BMI and type 1 diabetes mellitus, IgA nephropathy, adult Still disease, multiple sclerosis, narcolepsy, Hashimoto thyroiditis, autoimmune hepatitis, rheumatoid arthritis, psoriasis vulgaris and pernicious anemia.
李煜楠, 徐鹏程, 贾俊亚, 闫铁昆. 体质指数与25种自身免疫性疾病的孟德尔随机化研究[J]. 预防医学, 2024, 36(5): 388-392.
LI Yunan, XU Pengcheng, JIA Junya, YAN Tiekun. Mendelian randomization study on body mass index and 25 types of autoimmune diseases. Preventive Medicine, 2024, 36(5): 388-392.
[1] XIANG H,YANG R H,TU J X,et al.Health impacts of high BMI in China:terrible present and future[J/OL].Int J Environ Res Public Health,2022,19(23)[2024-04-07].https://doi.org/10.3390/ijerph19231617. [2] 孙霞,朱艳,郑鹏,等.超重肥胖和2型糖尿病对瘦素、内脂素的影响研究[J].预防医学,2022,34(6):581-585. [3] MATARESE G.The link between obesity and autoimmunity[J].Science,2023,379(6639):1298-1300. [4] XIANG Y,ZHANG M X,JIANG D,et al.The role of inflammation in autoimmune disease:a therapeutic target[J/OL].Front Immunol,2023,14[2024-04-07].https://doi.org/10.3389/fimmu.2023.1267091. [5] 任首泽,李泽光,李林蔚,等.自身免疫性疾病与甲状腺功能障碍的孟德尔随机化研究[J].预防医学,2023,35(12):1024-1028. [6] TSIGALOU C,VALLIANOU N,DALAMAGA M.Autoantibody production in obesity:is there evidence for a link between obesity and autoimmunity?[J].Curr Obes Rep,2020,9(3):245-254. [7] SONG R H,WANG B,YAO Q M,et al.The impact of obesity on thyroid autoimmunity and dysfunction:a systematic review and meta-analysis[J/OL].Front Immunol,2019,10[2024-04-07].https://doi.org/10.3389/fimmu.2019.02349. [8] WIECHERT M,HOLZAPFEL C.Nutrition concepts for the treatment of obesity in adults[J/OL].Nutrients,2021,14(1)[2024-04-07].https://doi.org/10.3390/nu14010169. [9] EMDIN C A,KHERA A V,KATHIRESAN S.Mendelian randomization[J].JAMA,2017,318(19):1925-1926. [10] 于天琦,徐文涛,苏雅娜,等.孟德尔随机化研究基本原理、方法和局限性[J].中国循证医学杂志,2021,21(10):1227-1234. [11] VERBANCK M,CHEN C Y,NEALE B,et al.Detection of wideSpread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases[J].Nat Genet,2018,50(5):693-698. [12] ZHOU H Y,WANG L W,LIU F.Immunological impact of intestinal t cells on metabolic diseases[J/OL].Front Immunol,2021,12[2024-04-07].https://doi.org/10.3389/fimmu.2021.639902. [13] KARAMPELA I,SAKELLIOU A,VALLIANOU N,et al.Vitamin D and obesity:current evidence and controversies[J].Curr Obes Rep,2021,10(2):162-180. [14] LI X L,ZHU J,ZHAO W M,et al.The causal effect of obesity on the risk of 15 autoimmune diseases:a Mendelian randomization study[J].Obes Facts,2023,16(6):598-605. [15] WU C W,WANG A Y,LI G S,et al.Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy[J/OL].BMC Nephrol,2018,19(1)[2024-04-07].https://doi.org/10.1186/s12882-018-1164-2. [16] DI COLA I,IACONO D,PANTANO I,et al.Clinical characteristics of obese patients with adult-onset still's disease.data from a large multicentre cohort[J/OL].Joint Bone Spine,2023,90(5)[2024-04-07].https://pubmed.ncbi.nlm.nih.gov/37080283/DOI:10.1016/j.jbspin.2023.105576. [17] ZHANG M,THIEUX M,INOCENTE C O,et al.Characterization of rapid weight gain phenotype in children with narcolepsy[J].CNS Neurosci Ther,2022,28(6):829-841. [18] RALLI M,ANGELETTI D,FIORE M,et al.Hashimoto's thyroiditis:an update on pathogenic mechanisms,diagnostic protocols,therapeutic strategies,and potential malignant transformation[J/OL].Autoimmun Rev,2020,19(10)[2024-04-07].https://doi.org/10.1016/j.autrev.2020.102649. [19] WILDING J P H.Endocrine testing in obesity[J].Eur J Endocrinol,2020,182(4):13-15. [20] CORTEZ A P B,DE MORAIS M B,SPERIDIÃO P DA G,et al.Food intake,growth and body composition of children and adolescents with autoimmune hepatitis[J/OL].J Clin Gastroenterol,2010,44(3)[2024-04-07].https://doi.org/10.1097/MCG.0b013e3181b9145a. [21] GAUR P,CEBULA M,RIEHN M,et al.Diet induced obesity has an influence on intrahepatic T cell responses[J].Metabolism,2017,69:171-176. [22] HTUT T W,THEIN K Z,OO T H.Pernicious anemia:pathophysiology and diagnostic difficulties[J].J Evid Based Med,2021,14(2):161-169. [23] ARSHAD M,JABERIAN S,PAZOUKI A,et al.Iron deficiency anemia and megaloblastic anemia in obese patients[J].Rom J Intern Med,2017,55(1):3-7.
